https://www.avient.com/sites/default/files/2020-10/auto-injector-application-study.pdf
1) AUTO-INJECTOR APPLICATION STUDY M A T E R I A L T E C H N O L O G I E S
+ S E R V I C E S F O R N E X T G E N E R A T I O N D E S I G N S Avient Corporation
https://www.avient.com/resources/safety-data-sheets?page=1913
MSDS X150-062-001-44
MSDS X150-062-001-45
MSDS X150-062-001-41
https://www.avient.com/resources/safety-data-sheets?page=1179
MSDS X155-058-075-02
MSDS X155-058-075-01
MSDS X155-058-098-02
https://www.avient.com/resources/safety-data-sheets?page=673
MSDS X155-058-073-03
MSDS X155-058-073-01
MSDS X155-058-073-04
https://www.avient.com/sites/default/files/resources/PolyOne%2520Investor%2520Presentation%2520Jefferies%25202013%2520Global%2520Industrial%2520Conference_Posting.pdf
GAAP Measures Page 3 -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&
2008 2010 2012 2012 PF** H1'13 2015 % o f O pe ra tin g In co m e* JV's PP&S
- - 2.5% Specialty platform OI - % of sales 1.5% 4.3% 8.4% 9.1% 6.1% PP&S
https://www.avient.com/sites/default/files/resources/POL%2520Credit%2520Suisse%2520IR%2520Presentation%2520w%2520non-GAAP%25209%252017%25202013.pdf
2005 2008 2010 2012 2012 PF** 2015 % o f O pe ra tin g In co m e* JV's PP&S
- - 2.5% Specialty platform OI - % of sales 1.5% 4.3% 8.4% 9.1% 6.1% PP&S
of sales - 4.4% - Specialty platform - OI % of sales 9.9% 9.5% 12.0% PP&S
https://www.avient.com/sites/default/files/resources/dB%2520June%2520Presentation%2520June%252012%25202013%2520%25282%2529.pdf
50.00% 0.00% 50.00% 100.00% 150.00% 200.00% 250.00% 300.00% 350.00% PolyOne S&
18% Industrial 10% Misc. 5% HealthCare 9% Transportation 16% Textiles 1% PP&S
Solutions -- 2.5% 4.6% Specialty platform OI % of sales 9.1% 6.1% 10.4% PP&S
https://www.avient.com/sites/default/files/2020-12/case-study-versaflex-ce-antimicrobial-phone-case-1.pdf
PHONE CASE BRAND P H O N E C A S E S • Compatible with antimicrobial additives
https://www.avient.com/sites/default/files/2020-10/coffee-capsules-case-study.pdf
Coffee Capsules case study DESIGN FOR COMPOSTING C O F F E E C A P S U L E S
https://www.avient.com/sites/default/files/2023-08/AVNT August IR Presentation w NonGAAP Recs%5B40%5D.pdf
AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) AU G
U S T 2 0 2 3 DISCLAIMER Forward-Looking Statements Certain statements contained
O U R E N G I N E E R E D F I B E R S A N D P A N E L S T E C H N O L O G Y